Normal view MARC view ISBD view

Development and Validation of UV Spectrophotometric and Stability Indicating RP-HPLC Assay Method for Agomelatine in Bulk and Pharmaceutical Formulations

By:

Material type: Film

FilmPublication details: Ahmedabad Institute of Pharmacy, Nirma University 2012Description: 109pDDC classification:

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

Holdings
Item type	Current library	Collection	Call number	Status	Notes	Date due	Barcode	Item holds
CD/DVD	NIMA Knowledge Centre	Reference	615.1901 SHA (Browse shelf(Opens below))	Not For Loan	Dissertation CD		PDR00186-1
Dissertation	NIMA Knowledge Centre	Reference	615.1901 SHA (Browse shelf(Opens below))	Not For Loan			PDR00186

Total holds: 0

Previous	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	No cover image available	Next
Previous	615.1901 SHA Development and Validation of UV Spectrophotometric, HPLC and RP-HPLC Methods for Simultaneous Estimation of Amlodipline Besylate. Hydrochlorothiazide and Valsartan in their Combined Tablet Dosage Form	615.1901 SHA Development and Validation of UV Spectrophotometric, HPLC and RP-HPLC Methods for Simultaneous Estimation of Amlodipline Besylate. Hydrochlorothiazide and Valsartan in their Combined Tablet Dosage Form	615.1901 SHA Development and Validation of UV Spectrophotometric and Stability Indicating RP-HPLC Assay Method for Agomelatine in Bulk and Pharmaceutical Formulations	615.1901 SHA Development and Validation of UV Spectrophotometric and Stability Indicating RP-HPLC Assay Method for Agomelatine in Bulk and Pharmaceutical Formulations	615.1901 SHA Development and Validation of UV Spectrophotometric and Hptlc Methods for Simultaneous Estimation of Tapentadol Hydrochloride and Paracetamol in their Combined Dosage Form	615.1901 SHA Development and Validation of UV Spectrophotometric and Hptlc Methods for Simultaneous Estimation of Tapentadol Hydrochloride and Paracetamol in their Combined Dosage Form	615.1901 SHA Development and Validation of Spectrophotometric and RP-HPLC for Simultaneous Estimation of Olanzapine and Fluoxetine Hydrochloride in Combined Dosage Form	Next

Guided by Dr. Priti J. Mehta Industrial Guide: Mr. VIjendrasignh

There are no comments on this title.

to post a comment.